Viewing Study NCT07317934


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 1:13 PM
Study NCT ID: NCT07317934
Status: RECRUITING
Last Update Posted: 2026-03-05
First Post: 2025-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)
Sponsor: Innostellar Biotherapeutics Co.,Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module